Special Programme on Human Reproduction: Difference between revisions

Revision as of 13:27, 30 April 2023

Revision as of 23:28, 15 November 2023

Line 20:

The Human Reproduction Unit continued its mission and expanded its research not to only take into account strictly the medical aspect of human reproduction, but also economic, sociological, cultural, and psychological factors. The Unit was organizing meetings of experts and began to create a centre of documentation on human reproduction. In 1970, the WHO designated the Reproductive Endocrinology Research Unit of the [[Karolinska Institute]] of [[Stockholm]] as research and training centre on human reproduction.<ref>{{Cite web|url=https://apps.who.int/iris/handle/10665/85828|title=The work of WHO, 1970: annual report of the Director-General to the World Health Assembly and to the United Nations|date=March 9, 1971|hdl=10665/85828 |last1=Candau |first1=Marcolino Gomes }}</ref>

Pleased by the progress made, the World Health Assembly requested the Director-General to consider a way to develop family planning services.<ref>{{Cite web|url=https://apps.who.int/iris/handle/10665/91257|title=Health aspects of population dynamics|date=March 9, 1969|hdl=10665/91257 }}</ref> In 1970, the WHO launched a feasibility study about a global program of research on human reproduction. A report was thus presented in 1971 and advocated for a five ways action plan.<ref>{{Cite web|url=https://apps.who.int/iris/bitstream/handle/10665/361192/HR-71.4-Pt1-eng.pdf?sequence=1&isAllowed=y|title=World Health Organization: Expanded Programme of Research, Development and Research Training in Human Reproduction: Report of a Feasibility Project, May 1971; HR/71.4 (1971) part 1.|hdl=10665/361192 }}</ref> First, the designation of four ''Research and Training Centres'', which would have to be leaders on the research on human reproduction in their respective region. Second, the collaboration with ''Clinical Research Centres'' to facilitate the clinical evaluation of new fertility regulating agents. Third, the creation of ''task Forces'' to conduct the research projects. Fourth, the creation of an international documentation centre on biomedical aspects of human reproduction (this point was not executed due to limited funding at the time). The fithfifth point was about secondary objectives and miscellaneous recommendations.

The Human Reproduction Unit was charged with the creation and administration of the new "Expanded Programme of Research, Development, and Research Training in Human Reproduction". In 1972, the World Health Assembly voted the WHA25.60 resolution "on WHO’s role in the development and coordination of biomedical research", which requested the Director-General to "prepare proposals for the development of long-term WHO activities

Line 33:

In 1986, the structure of the Programme changed.<ref>{{Cite web|url=https://apps.who.int/iris/bitstream/handle/10665/120636/em_rc33_13_en.pdf?sequence=1&isAllowed=y|title=World Health Organization: EM/RC33/13 - Nomination of a member state to the Policy and Coordination advisory committee (PCAC) of the Special programme of research, development, and research training in human reproduction (HRP), July 1986|hdl=10665/120636 }}</ref> The advisory Group was replaced by the Policy and Coordination Advisory Committee (PCAC), a consultative organ to the Director-General which made recommendations on issues linked to the policies, funding and general organization of the programme. It was composed of 30 members, twelve being the countries that contributed the most, twelve elected by the regional committees, three elected by the PCAC itself and the [[UNFPA]], [[World Bank]] and [[International Planned Parenthood Federation|IPPF]] as permanent members. The new structure also included the Scientific and Technical Advisory Group (STAG):<ref name=sponso>{{Cite web|url=https://apps.who.int/iris/bitstream/handle/10665/162389/EB81_22_eng.pdf?sequence=1&isAllowed=y|title=RECENT DEVELOPMENTS IN HUMAN REPRODUCTION RESEARCH - Progress report by the Director-General |hdl=10665/162389 }}</ref> composed of 10 to 15 members (experts and scientists) it designated the Programme research priorities, the creation or end of a task Force, and gave an independent evaluation of all scientific and technical aspect of the Programme.

In 1988, the co-sponsorship of the Programme began:<ref name=sponso /> the [[UNDP]], [[UNFPA]], [[World Bank]] and the [[WHO]] were co-sponsors of the "UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction", commonly referred to as "the HRP". This had to objective to obtain consequent and stable funding for the Programme. The PCAC became the Policy and Coordination Committee (PCC), in charge of the administration, the approval of the budget, and the general orientation of the work of the Programme and included the co-sponsors as permanent members. A Standing Committee, composed of representatives of the co-sponsors meets thrice a year, monitors the Programme situation and formulates recommendations to the PCC. As the executive agency, the WHO nominates the director of the Programme and other non-elected members of the HRP after consulting the Standing Committee. The STAG had also now to report to the Standing Committee while the Review Group is replaced by the Research Project Review Panel which had similar attributions, but includes also the control of the financial aspect of the research projects.

Finally, in 1996, the Gender Advisory Panel was created in order to keep particular attention to issues linked to gender inequities, mutilations and violence based on sex and rights based on sexual practice and orientation.<ref>{{Cite journal|title="Righting the wrongs": addressing human rights and gender equality through research since Cairo|first1=Rajat|last1=Khosla|first2=Avni|last2=Amin|first3=Pascale|last3=Allotey|first4=Carmen|last4=Barroso|first5=Asha|last5=George|first6=Anita|last6=Hardon|first7=Ian|last7=Askew|date=January 1, 2019|journal=Sexual and Reproductive Health Matters|volume=27|issue=1|pages=329–332|doi=10.1080/26410397.2019.1676529|pmid=31746277|pmc=7887975}}</ref> It became the Gender and Rights Advisory Panel in 2007.

Line 46:

==References==

{{Reflist}}

[[Category:Hormonal contraception]]